SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SciClone Pharmaceuticals (Holdings) Limited has announced that 31,000 share options were exercised under their Post-IPO Option Plan, resulting in the issue of the same number of new shares. Following this exercise, the company now has a total of 630,296,632 shares in issue. Additionally, there are 66,487,432 share options currently in issue across various plans, with a portion already vested and available for exercise.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.